JP2023518714A5 - - Google Patents

Info

Publication number
JP2023518714A5
JP2023518714A5 JP2022554747A JP2022554747A JP2023518714A5 JP 2023518714 A5 JP2023518714 A5 JP 2023518714A5 JP 2022554747 A JP2022554747 A JP 2022554747A JP 2022554747 A JP2022554747 A JP 2022554747A JP 2023518714 A5 JP2023518714 A5 JP 2023518714A5
Authority
JP
Japan
Prior art keywords
product
protein
enzyme
transglutaminase
transglutaminase enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2022554747A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023518714A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/021766 external-priority patent/WO2021183680A1/en
Publication of JP2023518714A publication Critical patent/JP2023518714A/ja
Publication of JP2023518714A5 publication Critical patent/JP2023518714A5/ja
Withdrawn legal-status Critical Current

Links

JP2022554747A 2020-03-13 2021-03-10 トランスグルタミナーゼ変種 Withdrawn JP2023518714A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062988918P 2020-03-13 2020-03-13
US62/988,918 2020-03-13
PCT/US2021/021766 WO2021183680A1 (en) 2020-03-13 2021-03-10 Transglutaminase variants

Publications (2)

Publication Number Publication Date
JP2023518714A JP2023518714A (ja) 2023-05-08
JP2023518714A5 true JP2023518714A5 (cg-RX-API-DMAC7.html) 2024-03-18

Family

ID=77671938

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022554747A Withdrawn JP2023518714A (ja) 2020-03-13 2021-03-10 トランスグルタミナーゼ変種

Country Status (9)

Country Link
US (1) US20230167420A1 (cg-RX-API-DMAC7.html)
EP (1) EP4118194A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023518714A (cg-RX-API-DMAC7.html)
KR (1) KR20220153047A (cg-RX-API-DMAC7.html)
CN (1) CN115298306A (cg-RX-API-DMAC7.html)
BR (1) BR112022017192A2 (cg-RX-API-DMAC7.html)
CA (1) CA3172844A1 (cg-RX-API-DMAC7.html)
MX (1) MX2022011077A (cg-RX-API-DMAC7.html)
WO (1) WO2021183680A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4526437A1 (en) 2022-05-20 2025-03-26 Curie Co. Inc. Pro-peptide variants for modulating activity of transglutaminases
CN115487345B (zh) * 2022-08-22 2024-03-12 天津大学 基于丝素蛋白的止血水凝胶和止血海绵及其制备方法和应用
CN121195062A (zh) 2023-05-19 2025-12-23 居里公司 转谷氨酰胺酶及其用途
CN117643311B (zh) * 2023-12-01 2024-09-27 北京舜雷科技有限公司 一种组合物、制备方法及应用
CN121610553B (zh) * 2026-01-30 2026-04-17 四川友联味业食品有限公司 一种鲜味肽提取物复配取代味精的加工工艺

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0807691T3 (da) * 1994-02-14 2002-02-04 Univ Leiden Fremgangsmåde til screening for tilstedeværelse af en genetisk defekt forbundet med trombose og/eller lav antikoagulant reaktion på aktiveret protein C
ES2372806T3 (es) * 1999-09-30 2012-01-26 Ajinomoto Co., Inc. Proceso para la producción de transglutaminasa.
RU2260051C2 (ru) * 2000-08-17 2005-09-10 Адзиномото Ко., Инк. Способ модифицирования трансглутаминаз микроорганизмов
JP2009504170A (ja) * 2005-08-18 2009-02-05 ノボ ノルディスク ヘルス ケア アーゲー 改善された特異性を有するトランスグルタミナーゼ変異体
EP2123756B1 (en) * 2007-02-15 2014-06-04 Ajinomoto Co., Inc. Transglutaminase having disulfide bond introduced therein
JP2008194004A (ja) * 2007-02-15 2008-08-28 Ajinomoto Co Inc 変異体トランスグルタミナーゼ
CN101945995B (zh) * 2008-02-13 2013-06-12 天野酶株式会社 稳定型转谷氨酰胺酶及其制造法
EP2404999B1 (en) * 2009-03-06 2015-04-29 Ajinomoto Co., Inc. Thermotolerant transglutaminase originating in actinomyces
US20200255813A1 (en) * 2017-07-09 2020-08-13 Igc Bio, Inc. Pross optimized enzymes
CN107739734B (zh) * 2017-10-26 2020-07-07 江南大学 一种酶活提高的谷氨酰胺转氨酶突变体
SG11202003094PA (en) * 2017-11-07 2020-05-28 Codexis Inc Transglutaminase variants
US20200370026A1 (en) * 2017-11-30 2020-11-26 Amano Enzyme Inc. Modified transglutaminase
EP3934426A4 (en) * 2019-03-06 2022-12-14 Curie Co., Inc. Preservative compositions and methods of use thereof
MX2023002744A (es) * 2020-09-08 2023-04-03 Curie Co Inc Composiciones y metodos de uso de las mismas.

Similar Documents

Publication Publication Date Title
US5304633A (en) Fragments of lactoferrin having potent antimicrobial activity
JP2023526199A5 (cg-RX-API-DMAC7.html)
US7550430B2 (en) Cationic antimicrobial peptides and compositions
CN107080831A (zh) 短抗微生物脂肽
JP2014501760A (ja) ヘアケア製品において使用するための酵素的な過酸の発生
JP2022522502A5 (cg-RX-API-DMAC7.html)
KR20220153047A (ko) 트랜스글루타미나제 변이체
JPH05148295A (ja) 抗菌性ペプチドおよび抗菌剤
KR20210137010A (ko) 방부제 조성물 및 이의 사용 방법
AU695290B2 (en) Improvements relating to antibacterial compositions
US20230203457A1 (en) Transglutaminase variants and applications of use thereof
CA3193765A1 (en) A personal care composition comprising amino acids
FR2771633A1 (fr) Composition synergique comportant au moins un n-octanyl aminoacide et au moins un n-undecylenoyl aminoacide; application en cosmetique
US20100008897A1 (en) Composition for providing a benefit to a keratin-containing substrate
JP7286908B2 (ja) 局所用組成物
CN115461034A (zh) 一种有效的抗痤疮个人护理组合物
RU2729405C1 (ru) Противомикробная смесь, содержащая 4-(3-этокси-4-гидроксифенил)бутан-2-он, и косметическая композиция, содержащая ее
WO2024243088A1 (en) Transglutaminases and uses thereof
KR102540535B1 (ko) 항균 펩타이드 및 이의 용도
AU2021263037B2 (en) Aerosol composition for sanitization
WO2015051260A2 (en) Skin care composition containing a biologic
AU2021263795B2 (en) Aerosol composition and method for sanitisation
CN114555040A (zh) 具有选择性抗微生物活性的带有茴香酸和乙酰丙酸的化妆品制剂
JPS62135432A (ja) 防黴剤